| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 316.28B | 346.81B | 316.88B | 312.83B | 301.37B | 281.42B |
| Gross Profit | 134.82B | 149.53B | 129.33B | 126.70B | 117.90B | 102.58B |
| EBITDA | 34.37B | 44.65B | 34.15B | 37.18B | 34.76B | 33.46B |
| Net Income | 24.52B | 31.10B | 23.88B | 22.96B | 21.84B | 22.14B |
Balance Sheet | ||||||
| Total Assets | 418.97B | 468.30B | 415.55B | 415.44B | 389.98B | 394.96B |
| Cash, Cash Equivalents and Short-Term Investments | 98.99B | 105.56B | 93.75B | 81.31B | 82.59B | 110.90B |
| Total Debt | 68.26B | 65.98B | 69.99B | 81.35B | 70.96B | 67.24B |
| Total Liabilities | 156.42B | 166.17B | 151.40B | 159.31B | 157.20B | 156.29B |
| Stockholders Equity | 254.49B | 293.18B | 255.92B | 247.66B | 224.18B | 229.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.60B | 18.69B | 18.65B | 1.49B | 25.13B |
| Operating Cash Flow | 0.00 | 38.82B | 35.77B | 34.56B | 16.58B | 34.69B |
| Investing Cash Flow | 0.00 | -14.49B | -10.03B | -12.70B | -13.50B | -9.55B |
| Financing Cash Flow | 0.00 | -18.66B | -12.54B | -26.99B | -40.09B | -19.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥530.07B | 13.06 | 9.36% | 3.61% | 9.44% | 30.20% | |
71 Outperform | ¥8.37T | 9.00 | 12.86% | 2.48% | 0.62% | 7.66% | |
69 Neutral | ¥9.00T | 20.63 | 13.39% | 2.29% | 6.11% | 9.13% | |
69 Neutral | ¥18.87T | 25.47 | 8.81% | 2.94% | 1.60% | -10.27% | |
68 Neutral | ¥15.05T | 17.70 | 15.23% | 2.11% | 0.67% | 3.97% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥16.32T | 19.09 | 11.47% | 2.28% | -4.55% | -5.17% |